News
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...
US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...
Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...
Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...
Looking at surging obesity drug sales, market share momentum, and an increased fair value estimate, here’s what we think of ...
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results